Notice Number: NOT-CA-17-029

Key Dates
Release Date: February 21, 2017

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform the scientific community about a change (effective immediately) to National Cancer Institute (NCI) PAR-16-189 “Paul Calabresi Career Development Award for Clinical Oncology (K12)".

Specifically, NCI will accept the appointment of clinician scientists still undergoing residency training as Paul Calabresi K12 Scholars, with a minimum of 50% of full-time professional effort (6 person-months) committed to the program.

Accordingly, the block "Scholars" in Section III.3. "Additional Information on Eligibility" of PAR-16-189 is amended as indicated below:

Current text:

Scholars
Scholars to be supported by the institutional career development program must be at the career level for which the planned program is intended, should not have reached research independence and should benefit from the proposed activities and experiences involved in the career development program.  Non-clinician postdoctoral researchers are expected to take part in clinical research, and to collaborate with K12-appointed clinician-scientists to expedite the translation of research discoveries into patient-oriented care.  There must be a minimum ratio of two clinicians (M.D.) for each non-clinician postdoctoral researcher (Ph.D.) appointed to the program at any one time. Scholars are expected to devote a minimum of 9 person-months (75% of full-time professional effort) during the appointment on the K12 award.

New text:

Scholars
Scholars to be supported by the institutional career development program must be at the career level for which the planned program is intended, should not have reached research independence and should benefit from the proposed activities and experiences involved in the career development program.  Non-clinician postdoctoral researchers are expected to take part in clinical research, and to collaborate with K12-appointed clinician-scientists to expedite the translation of research discoveries into patient-oriented care.  There must be a minimum ratio of two clinicians (M.D.) for each non-clinician postdoctoral researcher (Ph.D.) appointed to the program at any one time. Scholars, who are clinician scientists still undergoing residency training, are expected to devote a minimum of 6 person-months (50% of full-time professional effort) during the appointment on the K12 award. Scholars, who are not in residency training, are expected to devote a minimum of 9 person-months (75% of full-time professional effort) during the appointment on the K12 award.

All other aspects of PAR-16-189 remain unchanged.

Inquiries

Please direct all inquiries to:

Mark Damico, Ph.D.
National Cancer Institute
Telephone: 240-276-5630, ext. 1
Email: [email protected]